Skip to main content
. 2016 Jun 23;11(6):e0158307. doi: 10.1371/journal.pone.0158307

Fig 3. 18F-FDG PET/CT in patients with advanced lung adenocarcinoma.

Fig 3

a A 71-year-old man with high whole-body total lesion glycolysis (TLGWBR) determined using the Response Evaluation Criteria In Solid Tumors 1.1 criteria (7944.00) and primary tumor total lesion glycolysis (TLGT) (1250.46). Progression-free survival (PFS) was 5.9 months and overall survival (OS) was 11.9 months. EGFR mutation status was the wild-type. b A 68-year-old woman with low TLGWBR (179.74) and TLGT (142.41). PFS was 12.3 months and OS was 35.9 months. EGFR mutation status involved the mutation of exon 19 (delE746-A750).